doi: 10.1007/s10238-015-0345-6 5 SuGZhongZZhouQDuLYeZLiFet al
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide What patients do after stopping a GLP-1 medication and how their weight changes afterward turns out to be more varied than controlled trials have suggested
In one of the focus groups, there was no disagreement when one participant asked, [d]oes it feel almost inevitable that those drugs are going to become part of our formulary? Our insurance provider, Cigna told us that within the next 9 to 12 months, theres really not going to be a choice, that all insurance companies are probably going to be covering GLP-1s for weight loss. Occupational health manager, large manufacturer The use of GLP-1 drugs for weight loss is still new for many employers, and many are not sure how or whether they can manage the benefit
Deluxe runs 45 to 60 minutes
It doesn't directly modulate hormones
Neuroendocrine and Metabolic Research Contexts Beyond pituitary-focused studies, GHRP-2 and GHRP-6 have been investigated for their broader roles in neuroendocrine communication
